Lee Financial CO Dexcom Inc Transaction History

Lee Financial CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$75.49 - $124.16 $1,660 - $2,731	-22 Reduced 37.93%	36 $4,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $312 - $368	-3 Reduced 4.92%	58 $6,000
Q3 2022 Nov 01, 2022	BUY	$76.35 - $94.18 $687 - $847	9 Added 17.31%	61 $5,000
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $3,263 - $6,378	48 Added 1200.0%	52 $4,000
Q2 2021 Aug 04, 2021	SELL	$80.99 - $107.93 $485 - $647	-6 Reduced 60.0%	4 $2,000
Q1 2020 May 07, 2020	BUY	$47.79 - $75.63 $477 - $756	10 New	10 $3,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.